{"id":"W2166886145","doi":"10.1111/dom.12527","title":"Treatment satisfaction in people with type 2 diabetes mellitus treated with once‐weekly dulaglutide: data from the <scp>AWARD</scp> ‐1 and <scp>AWARD</scp> ‐3 clinical trials","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Type 2 Diabetes Mellitus; Liraglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005205159,0.0002484941,0.001051842,0.0005069127,0.0002431978,0.0005959152,0.0002824891,0.0005376276,0.001668642],"category_scores_gemma":[0.005650178,0.0001878237,0.002313302,0.001445598,0.0001947896,0.0003850927,0.000412929,0.0006358227,0.0001537244],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003633124,"about_ca_system_score_gemma":0.0003455738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00172543,"about_ca_topic_score_gemma":0.002562256,"domain_scores_codex":[0.9971854,0.001536796,0.0004262131,0.0001315599,0.0006116865,0.000108322],"domain_scores_gemma":[0.9939605,0.002187593,0.002652246,0.0001375065,0.0005860709,0.0004761359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03286506,0.0008091429,0.9020745,0.00183978,0.004941451,0.00005693849,0.000354654,0.0004127099,0.0005644614,0.0000513124,0.001595248,0.05443469],"study_design_scores_gemma":[0.003168037,0.004714939,0.9880597,0.0001492577,0.001551881,0.00012731,0.0001881179,0.0004919362,0.0001903153,0.00003438642,0.00130071,0.0000233896],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840059,0.009416206,0.0003772595,0.0003504071,0.0000547228,0.0002563897,0.003774989,0.00001519645,0.001748916],"genre_scores_gemma":[0.9941112,0.002153264,0.0003305651,0.0002610939,0.00004285371,0.0002616747,0.002595815,0.000004305839,0.0002391809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005205159,"threshold_uncertainty_score":0.02752781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07220703135005108,"score_gpt":0.3189510850167525,"score_spread":0.2467440536667014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}